Cargando…

Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania

The aim of the study was to compare telomere lengths and circulating proteasome concentrations in patients with different stages of diabetic retinopathy and type 1 diabetes in Latvia and Lithuania. Methods. Patients with no diabetic retinopathy and with non-proliferative diabetic retinopathy were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Svikle, Zane, Pahirko, Leonora, Zariņa, Līga, Baumane, Kristīne, Kardonaite, Deimante, Radzeviciene, Lina, Daugintyte-Petrusiene, Laura, Balciuniene, Vilma Jurate, Verkauskiene, Rasa, Tiščuka, Angeļina, Rovite, Vita, Sjakste, Nikolajs, Sokolovska, Jelizaveta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146024/
https://www.ncbi.nlm.nih.gov/pubmed/35628895
http://dx.doi.org/10.3390/jcm11102768
_version_ 1784716458737008640
author Svikle, Zane
Pahirko, Leonora
Zariņa, Līga
Baumane, Kristīne
Kardonaite, Deimante
Radzeviciene, Lina
Daugintyte-Petrusiene, Laura
Balciuniene, Vilma Jurate
Verkauskiene, Rasa
Tiščuka, Angeļina
Rovite, Vita
Sjakste, Nikolajs
Sokolovska, Jelizaveta
author_facet Svikle, Zane
Pahirko, Leonora
Zariņa, Līga
Baumane, Kristīne
Kardonaite, Deimante
Radzeviciene, Lina
Daugintyte-Petrusiene, Laura
Balciuniene, Vilma Jurate
Verkauskiene, Rasa
Tiščuka, Angeļina
Rovite, Vita
Sjakste, Nikolajs
Sokolovska, Jelizaveta
author_sort Svikle, Zane
collection PubMed
description The aim of the study was to compare telomere lengths and circulating proteasome concentrations in patients with different stages of diabetic retinopathy and type 1 diabetes in Latvia and Lithuania. Methods. Patients with no diabetic retinopathy and with non-proliferative diabetic retinopathy were included in the NDR/NPDR group (n = 187). Patients with proliferative diabetic retinopathy and status post laser-photocoagulation were included int the PDR/LPC group (n = 119). Telomeres were evaluated by real-time quantitative polymerase chain reaction. Proteasome concentration was measured by ELISA. Results. Telomeres were longer in PDR/LPC (ΔCT 0.21 (0.12–0.28)) vs. NDR/NPDR (ΔCT 0.18 (0.1–0.28)), p = 0.036. In NDR/NPDR, telomeres were correlated negatively with age (R = −0.17, p = 0.019), BMI (R = −0.21, p = 0.004), waist/hip ratio (R = −0.21, p = 0.005), total cholesterol (R = −0.18, p = 0.021), and low-density cholesterol (R = −0.20, p = 0.010), and positively with estimated glomerular filtration rate (eGFR) (R = 0.28, p < 0.001). None of the above correlations were observed in PRD/LPC. Proteasome concentrations were lower in PDR/LPC (130 (90–210) ng/mL) vs. NDR/NPDR (150 (100–240) ng/mL), p = 0.024. This correlated negatively with eGFR (R = −0.17, p = 0.025) in the NDR/NPDR group and positively with age (R = 0.23, p = 0.014) and systolic blood pressure (R = 0.20, p = 0.032) in the PRD/LPC group. Telomere lengths did not correlate with proteasome concentrations. Conclusion. Longer telomeres and lower circulating proteasome concentrations are observed in patients with type 1 diabetes and advanced diabetic retinopathy.
format Online
Article
Text
id pubmed-9146024
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91460242022-05-29 Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania Svikle, Zane Pahirko, Leonora Zariņa, Līga Baumane, Kristīne Kardonaite, Deimante Radzeviciene, Lina Daugintyte-Petrusiene, Laura Balciuniene, Vilma Jurate Verkauskiene, Rasa Tiščuka, Angeļina Rovite, Vita Sjakste, Nikolajs Sokolovska, Jelizaveta J Clin Med Article The aim of the study was to compare telomere lengths and circulating proteasome concentrations in patients with different stages of diabetic retinopathy and type 1 diabetes in Latvia and Lithuania. Methods. Patients with no diabetic retinopathy and with non-proliferative diabetic retinopathy were included in the NDR/NPDR group (n = 187). Patients with proliferative diabetic retinopathy and status post laser-photocoagulation were included int the PDR/LPC group (n = 119). Telomeres were evaluated by real-time quantitative polymerase chain reaction. Proteasome concentration was measured by ELISA. Results. Telomeres were longer in PDR/LPC (ΔCT 0.21 (0.12–0.28)) vs. NDR/NPDR (ΔCT 0.18 (0.1–0.28)), p = 0.036. In NDR/NPDR, telomeres were correlated negatively with age (R = −0.17, p = 0.019), BMI (R = −0.21, p = 0.004), waist/hip ratio (R = −0.21, p = 0.005), total cholesterol (R = −0.18, p = 0.021), and low-density cholesterol (R = −0.20, p = 0.010), and positively with estimated glomerular filtration rate (eGFR) (R = 0.28, p < 0.001). None of the above correlations were observed in PRD/LPC. Proteasome concentrations were lower in PDR/LPC (130 (90–210) ng/mL) vs. NDR/NPDR (150 (100–240) ng/mL), p = 0.024. This correlated negatively with eGFR (R = −0.17, p = 0.025) in the NDR/NPDR group and positively with age (R = 0.23, p = 0.014) and systolic blood pressure (R = 0.20, p = 0.032) in the PRD/LPC group. Telomere lengths did not correlate with proteasome concentrations. Conclusion. Longer telomeres and lower circulating proteasome concentrations are observed in patients with type 1 diabetes and advanced diabetic retinopathy. MDPI 2022-05-13 /pmc/articles/PMC9146024/ /pubmed/35628895 http://dx.doi.org/10.3390/jcm11102768 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Svikle, Zane
Pahirko, Leonora
Zariņa, Līga
Baumane, Kristīne
Kardonaite, Deimante
Radzeviciene, Lina
Daugintyte-Petrusiene, Laura
Balciuniene, Vilma Jurate
Verkauskiene, Rasa
Tiščuka, Angeļina
Rovite, Vita
Sjakste, Nikolajs
Sokolovska, Jelizaveta
Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title_full Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title_fullStr Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title_full_unstemmed Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title_short Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
title_sort telomere lengths and serum proteasome concentrations in patients with type 1 diabetes and different severities of diabetic retinopathy in latvia and lithuania
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146024/
https://www.ncbi.nlm.nih.gov/pubmed/35628895
http://dx.doi.org/10.3390/jcm11102768
work_keys_str_mv AT sviklezane telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT pahirkoleonora telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT zarinaliga telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT baumanekristine telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT kardonaitedeimante telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT radzevicienelina telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT daugintytepetrusienelaura telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT balciunienevilmajurate telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT verkauskienerasa telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT tiscukaangelina telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT rovitevita telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT sjakstenikolajs telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania
AT sokolovskajelizaveta telomerelengthsandserumproteasomeconcentrationsinpatientswithtype1diabetesanddifferentseveritiesofdiabeticretinopathyinlatviaandlithuania